The Prevalence of Cervical Cancer among Females Living with HIV/AIDS in Wuse District Hospital, Abuja, Nigeria: Epidemiological Trends and Health Outcomes
Abstract:
Cervical cancer remains a significant public health
challenge, particularly among women living with HIV/AIDS. This paper aims to
explore the prevalence and health outcomes associated with cervical cancer
among females living with HIV/AIDS in Abuja, Nigeria. To
achieve this objective, a cross-sectional retrospective study design was used
to determine the prevalence of cervical cancer in females living with HIV
between January 2022 to December 2023. Data was collected by use of folders and
clients’ records, well-articulated personal interviews, questionnaires and
forms. A random sampling method was adopted to make sure that all important
groups are captured including different age grades, socioeconomic status,
cultural beliefs, tribe, marital status, educational level, religion, sexual
behavior, and parity. Data extracted was inputted in Microsoft Excel 2010,
analysis was done using statistical software SPSS (Statistical Package for
Social Sciences). At the end of this analysis, the result showed that the
prevalence of cervical cancer among females living with HIV/AIDS in Abuja is 4%
which indicates that cervical cancer is a significant public health issue among
HIV-positive women in Abuja. While this rate may appear modest, it is
considerably higher than the general population, underscoring the heightened
risk faced by females living with HIV.
References:
[1].
Abugu, L. I., Nwagu, E. N., 2021,
Awareness, Knowledge and Screening for Cervical Cancer Among Women of a
Faith-Based Organization in Nigeria. The Pan African Medical Journal,
39: 200, https://doi.org/10.11604/pamj.2021.39.200.23761.
[2].
Aboulafia, D. M., Bundow, D., 2000, AIDS-related
Cervical Cancer: an Evolving Epidemic. Journal of the National Medical
Association, 92(9), 463-467.
[3]. Adler,
D. H., Wallace, M., Bennie, T., Abar, B., Meiring, T. L., de Bruyn, G., Bekker,
L. G., 2012, Cervical Dysplasia and HIV Infection in High-risk Women in South
Africa. AIDS, 26(17), 2149-2155.
[4].
Agba,
E. J., Curado, M. P., Ogunbiyi, O., Oga, E., Fabowale, T., Igbinoba, F., Osubor,
G., Otu, T., Kumai, H., Koechlin, A., Osinubi, P., Dakum, P., Blattner, W.,
Adebamowo, C A., 2012, Cancer Incidence in Nigeria: A Report from
Population-Based Cancer Registries. Cancer Epidemiology, 36, 271-278, https://doi.org/10.1016/j.canep.2012.04.007.
[5]. Anorlu, R. I., 2008, Cervical cancer: the sub-Saharan African
perspective. Reproductive Health Matters, 16(32), 41-49, https://doi.org/10.1016/S0968-8080(08)32415-X.
[6]. Bisi-Onyemaechi,
A. I., Chikani, U. N., Nduagubam, O., 2018, Reducing Incidence of Cervical
Cancer: Knowledge and Attitudes of Caregivers in Nigerian City to Human
Papilloma Virus Vaccination. Infectious Agents and Cancer, 13: 29, https://doi.org/10.1186/s13027-018-0202-9.
[7]. Clifford,
G. M., Gallus, S., Herrero, R., Munoz, N., Snijders, P. J. F., Vaccarella, S.,
Anh, P. T. H., Ferrecio, C., Hieu, N. T., Matos, E., Molano, M., Rajkumar, R.,
Ronco, G., de Sanjose, S., Shin, H. R., Sukvirach, S., Thomas, J. O., Tunsakul,
S., Meijer, C. J. L. M., Franceschi, S., 2005, Worldwide Distribution of Human
Papillomavirus Types in Cytologically Normal Women in the International Agency
for Research on Cancer HPV prevalence surveys: a pooled analysis. The Lancet,
366(9490), 991-998, https://doi.org/10.1016/S0140-6736(05)67069-9.
[8].
Ferlay, J., Colombet, M.,
Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., Bray,
F., 2019, Estimating the global cancer incidence and mortality in 2018:
GLOBOCAN sources and methods. International Journal of Cancer, 144(8),
1941-1953, https://doi.org/10.1002/ijc.31937.
[9].
Frisch, M., Biggar, R. J., Engels, E.
A., 2001, Association of Cancer with AIDS-related Immunosuppression in Adults. JAMA,
285(13), 1736-1745, https://doi.org/10.1001/jama.285.13.1736.
[10]. Gakidou,
E., Nordhagen, S., Obermeyer, Z., 2008, Coverage of Cervical Cancer Screening
in 57 Countries: Low Average Levels and Large Inequalities. PLOS Medicine,
5(6), e132, https://doi.org/10.1371/journal.pmed.0050132.
[11]. Ghebre,
R. G., Grover, S., Xu M. J., Chuang, L. T., Simonds, H., 2017, Cervical Cancer
Control in HIV Infected Women: Past, Present and Future. Gynecologic
Oncology Reports, 21: 101-108, https://doi.org/10.1016/j.gore.2017.07.009.
[12].
Gichangi, P., Vuyst, H., Estambale, B.,
Rogo, K., Bwayo, J., Temmerman, M., 2002, HIV and Cervical Cancer in Kenya. International
Journal of Gynecology & Obstetrics, 83(2), 141-143, https://doi.org/10.1016/s0020-7292(01)00560-4.
[13]. Heard, I., Tassie, J. M., Kazatchkine, M. D., Orth, G., 2013, Increased
risk of cervical squamous intraepithelial lesions in HIV-infected women with
severe immunosuppression. AIDS, 24(7), 1069-1074.
[14].
Kani, Y. A., Muhammad, Y., Binji, A.,
Iliya, S., Adejumo, R., Kamilu, I. M., Isah, M., 2020, Prevalence of Cervical
Cancer - A 6 year Retrospective Study in Jigawa State Nigeria. World Journal
of Biology Pharmacy and Health Sciences, 4: 8 – 13.
[15].
Liu, G., Sharma, M., Tan, N., Barnabas,
R. V., 2018, HIV-positive women have higher risk of HPV infection, precancerous
lesions, and cervical cancer. AIDS, 32: 795-808, https://doi.org/10.1097/QAD.0000000000001765.
[16].
Lv, T., Cao, W., Li, T., 2021,
HIV-Related Immune Activation and Inflammation: Current Understanding and
Strategies. Journal of Immunology Research, https://doi.org/10.1155/2021/7316456.
[17].
Maiman, M., Fruchter, R. G., Guy, L.,
Cuthill, S., Levine, P., Serur, E., 1997, Human Immunodeficiency Virus
Infection and Invasive Cervical Carcinoma. Cancer, 79(2), 271-276.
[18]. Mwesigire, D. M., Martin,
F., Seeley, J., Katamba, A., 2015, Relationship between CD4 count and quality
of life over time among HIV patients in Uganda: a cohort study. Health and
Quality Life Outcomes, 13:144, https://doi.org/10.1186/s12955-015-0332-3.
[19].
Ndikom, C. M., Ofi, B. A., 2012,
Awareness, Perception and Factors Affecting Utilization of Cervical Cancer
Screening Services Among Women in Ibadan, Nigeria: A Qualitative Study. Reproductive
Health, 9(1), 11, https://doi.org/10.1186/1742-4755-9-11.
[20]. Ngcobo, N., Jaca A.,
Iwu-Jaja, C. A., Mavundza, E., 2021, Reflection: Burden of Cervical Cancer in
Sub-Saharan Africa and Progress with HPV Vaccination. National Library of
Medicine, 71: 21-26, https://doi.org/10.1016/j.coi.2021.03.006.
[21]. Ojha, P. S., Maste, M. M., Tubachi, S.,
Patil, V. S., 2022, Human Papillomavirus and Cervical Cancer: an Insight
Highlighting Pathogenesis and Targeting strategies. Virus Disease, 33
(2) 132-154, https://doi.org/10.1007/s13337-022-00768-w.
[22]. Ononogbu, U., Almujtaba,
M., Modibbo, F., Lawal, I., Offiong, R., Olaniyan, O., Dakum, P., Speigelman, D.,
Blattner, W., Adebamowo, C., 2013, Cervical Cancer Risk factors among
HIV-Infected Nigerian Women. BMC Public Health, 13:582, https://doi.org/10.1186/1471-2458-13-582.
[23].
Palefsky, J. M., 2003, Cervical human
papillomavirus infection and cervical intraepithelial neoplasia in women
positive for human immunodeficiency virus in the era of highly active
antiretroviral therapy. Current Opinion in Oncology, 15(5), 382-388, https://doi.org/10.1097/00001622-200309000-00007.
[24].
Panatto, D., Amicizia, D., Trucchi,
C., Casabona, F., Lai, P. L., Bonanni, P., Boccalini, S., Bechini, A., Tiscione,
E., Zotti, C. M., Coppola, R. C., Masia, G., Meloni, A., Castiglia, P., Piana,
A., Gasparini, R., 2012, Sexual Behaviour and Risk Factors for the Acquisition
of Human Papillomavirus Infections in Young People in Italy: Suggestions for
Future Vaccination Policies. Maternal Health, Neonatology and Perinatology,
12:623, https://doi.org/10.1186/1471-2458-12-623.
[25].
Simen-Kapeu, A., 2009, Epidemiological
Study of Tobacco Use and Human Papillomavirus Implications for Public Health
Prevention. National Institute for Health and Welfare.
[26]. Stelzle,
D., Tanak, L. F., Lee, K. K., Khalil, A. I., Baussano, I., Shah, A. S. V.,
McAllister, D. A., Gottlieb, S. L., Klug, S. J., Winkler, A. S., Bray, F.,
Baggalay, R., Clifford, G. M., Broutet, N,, Dalal, S., 2020, Estimates of
Global Burden of Cervical Cancer associated with HIV. The Lancet Global
Health, 9: 161-169, https://doi.org/10.1016/S2214-109X(20)30459-9.
[27].
UNAIDS, 2019, Global HIV & AIDS
statistics—2020 fact sheet.
[28].
Van Gerwen, O. T., Muzny, C. A.,
Marrazzo, J. M., 2022, Sexually Transmitted Infections and Female Reproductive
Health. Nature Microbiology, 7 :1116–1126, https://doi.org/10.1038/s41564-022-01177-x.
[29].
WHO, 2014, Comprehensive cervical
cancer control: a guide to essential practice. World Health Organization.
[30].
Zhao, M., Wu, Q., Hao, Y., Hu, J., Gao,
Y., Zhou, S., Han, L., 2021, Global, regional, and national burden of cervical
cancer for 195 countries and territories, 2007 – 2017: findings from Global
Burden of Disease Study 2017. BMC Women’s Health.
[31]. Zhetpisbayeva, I., Kassymbekova, F., Sarmuldayeva, S., Semenova, Y., Glushkova, N., 2023, Cervical Cancer Prevention in Rural Areas. Annals of Global Health, 89(1): 75, https://doi.org/10.5334/aogh.4133.
